Lactobacillus reuteri
Lactobacillus reuteri NCIMB 30242
NCIMB 30242 (RBC)
Supporting healthy LDL and total cholesterol levels.
Quick Overview
At a Glance
Researched Benefits
- Clinically shown to help lower LDL ('bad') cholesterol and total cholesterol in multiple rigorous human trials
- Supports heart health through a unique gut-based mechanism — no harsh side effects like those sometimes linked to conventional approaches
- Bonus benefit: may help raise vitamin D levels, making it a two-for-one for your overall wellness
- Well-tolerated and backed by a strong safety record across multiple placebo-controlled studies
Usage & Application
Clinically Studied Dosage
2.9–5.8 Billion CFU/day (taken twice daily with meals)
Available Forms
Researched For
Clinical Evidence
Cholesterol and LDL Support from a Clinically Studied Probiotic: Lactobacillus reuteri NCIMB 30242
Your gut and your heart are more connected than most people realize — and Lactobacillus reuteri NCIMB 30242 sits right at that intersection. This carefully selected strain was chosen from thousands of bacteria for one very special talent: it produces an enzyme called bile salt hydrolase (BSH) at unusually high levels. Here's why that matters. Your liver makes bile — a digestive fluid packed with cholesterol — and sends it into your gut to help break down fats. Normally, most of that bile (and the cholesterol inside it) gets reabsorbed back into your bloodstream. But when NCIMB 30242 gets to work, it chemically alters those bile acids in a way that makes them much harder to reabsorb. The gut is then forced to excrete them, and your liver has to pull cholesterol out of your blood to make fresh bile. Think of this strain as a clever drain plug remover — it keeps cholesterol from cycling back where it doesn't belong and encourages your body to flush it out naturally.
The results people experience on this strain are genuinely impressive for a probiotic. In multiple gold-standard clinical trials involving adults with elevated cholesterol, participants taking this strain saw their LDL cholesterol — the type most associated with heart disease risk — fall by roughly 9 to 12 percent compared to those taking a placebo. Total cholesterol dropped alongside it, and markers linked to cardiovascular inflammation also improved meaningfully. For many people, that kind of shift starts to show up within just six weeks. Beyond cholesterol, participants in these studies also reported improvements in general digestive comfort — less diarrhea, a calmer stomach, and an overall sense of better gut health. And here's an unexpected bonus that genuinely surprised researchers: people taking this probiotic also saw a significant rise in their vitamin D levels. Because NCIMB 30242 influences how the gut handles fats and sterols, it appears to support better absorption of fat-soluble vitamins like vitamin D — something no other probiotic had been shown to do at the time. For anyone who already struggles with low vitamin D (which is most of us), that's a meaningful side benefit.
One of the biggest green flags for Lactobacillus reuteri NCIMB 30242 is its safety record. Clinical trials lasting up to nine weeks found no meaningful differences in adverse events between people taking this strain and those taking a sugar pill — meaning it's extremely well-tolerated. This strain carries GRAS (Generally Recognized as Safe) status and is appropriate for most healthy adults looking to support their cardiovascular wellness through diet and lifestyle. It's particularly well-suited for people with mildly to moderately elevated LDL who want a natural, evidence-backed complement to a heart-healthy diet. You'll find it most often in capsule form, and taking it twice daily with meals appears to be the sweet spot for effectiveness. As always, if you're already on cholesterol-lowering medication or have a diagnosed heart condition, have a conversation with your doctor before adding any supplement — this strain is a support tool, not a replacement for medical care.
Common Questions
Frequently Asked Questions
Sources
Scientific References
Curated By

Clara Hayes
Lead Research Editor
Clara leads the curation and verification of microbiome research for our platform. With extensive experience in translating complex scientific literature into accessible insights, she ensures every strain profile is grounded in peer-reviewed evidence and contextual accuracy.
Medical Disclaimer
The information provided on probioticstrains.com is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Strain profiles and clinical summaries are compiled from published peer-reviewed literature. While we may evaluate or highlight specific commercial formulations, our insights are always grounded in available scientific evidence. Always consult a qualified healthcare provider before starting, changing, or stopping any supplement or health regimen.